Spyglass Pharma Inc (SGP)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione Storia dei dividendi

Spyglass Pharma Inc Azioni (SGP) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2026-06-30	2026-03-31	2009-12-31	2009-09-30	2009-06-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Operating Expenses	42.56% 21.97	15.41	-	-	-
Operating Income/Loss	42.56% -21.97	-15.41	-	-	-
Nonoperating Income/Loss	32.18% 2.103	1.591	-	-	-
Income/Loss From Continuing Operations Before Tax	43.75% -19.86	-13.82	13,889.30	4,499.00	4,647.00
Income Tax Expense/Benefit	-	-	1,939.60	97.00	102.00
Net Income/Loss	43.75% -19.86	-13.82	11,033.20	515.00	671.00
Basic Average Shares	67.80% 33.44	19.93	-	-	-
Diluted Average Shares	67.80% 33.44	19.93	-	-	-
Basic Earnings Per Share	14.49% -0.59	-0.69	4.53	0.29	0.38
Diluted Earnings Per Share	14.49% -0.59	-0.69	4.52	0.29	0.38

AVBP

$16.79

3.64%

CRVS

$9.85

5.01%

VSTM

$9.23

19.71%

ALMS

$6.31

4.13%

ARDX

$3.27

2.51%

ODTX

$17.57

5.84%